List of Tables
Table 1. Global Uric Acid-lowering Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Uric Acid-lowering Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Uric Acid-lowering Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Uric Acid-lowering Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Uric Acid-lowering Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Uric Acid-lowering Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Uric Acid-lowering Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Uric Acid-lowering Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Uric Acid-lowering Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Uric Acid-lowering Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Uric Acid-lowering Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Uric Acid-lowering Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Uric Acid-lowering Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Uric Acid-lowering Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Uric Acid-lowering Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Uric Acid-lowering Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Uric Acid-lowering Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Uric Acid-lowering Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Uric Acid-lowering Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Uric Acid-lowering Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Uric Acid-lowering Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Uric Acid-lowering Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Uric Acid-lowering Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Uric Acid-lowering Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Uric Acid-lowering Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Uric Acid-lowering Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Uric Acid-lowering Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Uric Acid-lowering Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Uric Acid-lowering Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Uric Acid-lowering Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Uric Acid-lowering Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Uric Acid-lowering Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Uric Acid-lowering Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Uric Acid-lowering Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Uric Acid-lowering Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Uric Acid-lowering Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Uric Acid-lowering Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Uric Acid-lowering Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Uric Acid-lowering Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Uric Acid-lowering Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Uric Acid-lowering Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Uric Acid-lowering Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Uric Acid-lowering Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Uric Acid-lowering Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Uric Acid-lowering Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Uric Acid-lowering Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Uric Acid-lowering Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Uric Acid-lowering Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Uric Acid-lowering Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Uric Acid-lowering Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Uric Acid-lowering Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Uric Acid-lowering Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Uric Acid-lowering Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Uric Acid-lowering Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Uric Acid-lowering Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Uric Acid-lowering Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Uric Acid-lowering Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Uric Acid-lowering Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Uric Acid-lowering Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Uric Acid-lowering Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Uric Acid-lowering Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Uric Acid-lowering Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Uric Acid-lowering Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Uric Acid-lowering Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Uric Acid-lowering Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Uric Acid-lowering Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Uric Acid-lowering Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Uric Acid-lowering Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Teva Company Information
Table 71. Teva Description and Business Overview
Table 72. Teva Uric Acid-lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Teva Uric Acid-lowering Drugs Product
Table 74. Teva Recent Developments/Updates
Table 75. Mylan Pharmaceuticals Company Information
Table 76. Mylan Pharmaceuticals Description and Business Overview
Table 77. Mylan Pharmaceuticals Uric Acid-lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Mylan Pharmaceuticals Uric Acid-lowering Drugs Product
Table 79. Mylan Pharmaceuticals Recent Developments/Updates
Table 80. Takeda Pharmaceuticals Company Information
Table 81. Takeda Pharmaceuticals Description and Business Overview
Table 82. Takeda Pharmaceuticals Uric Acid-lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Takeda Pharmaceuticals Uric Acid-lowering Drugs Product
Table 84. Takeda Pharmaceuticals Recent Developments/Updates
Table 85. Sanwa Kagaku Kenkyusho Company Information
Table 86. Sanwa Kagaku Kenkyusho Description and Business Overview
Table 87. Sanwa Kagaku Kenkyusho Uric Acid-lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Sanwa Kagaku Kenkyusho Uric Acid-lowering Drugs Product
Table 89. Sanwa Kagaku Kenkyusho Recent Developments/Updates
Table 90. Towa Pharmaceutical Company Information
Table 91. Towa Pharmaceutical Description and Business Overview
Table 92. Towa Pharmaceutical Uric Acid-lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Towa Pharmaceutical Uric Acid-lowering Drugs Product
Table 94. Towa Pharmaceutical Recent Developments/Updates
Table 95. Toa Eiyo Company Information
Table 96. Toa Eiyo Description and Business Overview
Table 97. Toa Eiyo Uric Acid-lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Toa Eiyo Uric Acid-lowering Drugs Product
Table 99. Toa Eiyo Recent Developments/Updates
Table 100. AstraZeneca Company Information
Table 101. AstraZeneca Description and Business Overview
Table 102. AstraZeneca Uric Acid-lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. AstraZeneca Uric Acid-lowering Drugs Product
Table 104. AstraZeneca Recent Developments/Updates
Table 105. Mochida Pharmaceutical Company Information
Table 106. Mochida Pharmaceutical Description and Business Overview
Table 107. Mochida Pharmaceutical Uric Acid-lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Mochida Pharmaceutical Uric Acid-lowering Drugs Product
Table 109. Mochida Pharmaceutical Recent Developments/Updates
Table 110. Lannett Company Company Information
Table 111. Lannett Company Description and Business Overview
Table 112. Lannett Company Uric Acid-lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Lannett Company Uric Acid-lowering Drugs Product
Table 114. Lannett Company Recent Developments/Updates
Table 115. Horizon Therapeutics Company Information
Table 116. Horizon Therapeutics Description and Business Overview
Table 117. Horizon Therapeutics Uric Acid-lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Horizon Therapeutics Uric Acid-lowering Drugs Product
Table 119. Horizon Therapeutics Recent Developments/Updates
Table 120. Sanofi Company Information
Table 121. Sanofi Description and Business Overview
Table 122. Sanofi Uric Acid-lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Sanofi Uric Acid-lowering Drugs Product
Table 124. Sanofi Recent Developments/Updates
Table 125. GSK Company Information
Table 126. GSK Description and Business Overview
Table 127. GSK Uric Acid-lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. GSK Uric Acid-lowering Drugs Product
Table 129. GSK Recent Developments/Updates
Table 130. Fuji Yakuhin Company Information
Table 131. Fuji Yakuhin Description and Business Overview
Table 132. Fuji Yakuhin Uric Acid-lowering Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Fuji Yakuhin Uric Acid-lowering Drugs Product
Table 134. Fuji Yakuhin Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Uric Acid-lowering Drugs Distributors List
Table 138. Uric Acid-lowering Drugs Customers List
Table 139. Uric Acid-lowering Drugs Market Trends
Table 140. Uric Acid-lowering Drugs Market Drivers
Table 141. Uric Acid-lowering Drugs Market Challenges
Table 142. Uric Acid-lowering Drugs Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Uric Acid-lowering Drugs
Figure 2. Global Uric Acid-lowering Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Uric Acid-lowering Drugs Market Share by Type: 2025 & 2032
Figure 4. Uric Acid Production Inhibitors Product Picture
Figure 5. Urate-stimulating Excretion Agents Product Picture
Figure 6. Uric Acid Dissolving Agents Product Picture
Figure 7. Global Uric Acid-lowering Drugs Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Uric Acid-lowering Drugs Market Share by Application: 2025 & 2032
Figure 9. Hyperuricemia
Figure 10. Uric Acid Kidney Stones
Figure 11. Gout
Figure 12. Other
Figure 13. Global Uric Acid-lowering Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Uric Acid-lowering Drugs Market Size (US$ Million), 2021–2032
Figure 15. Global Uric Acid-lowering Drugs Sales (K Units), 2021–2032
Figure 16. Global Uric Acid-lowering Drugs Average Price (US$/Unit), 2021–2032
Figure 17. Uric Acid-lowering Drugs Report Years Considered
Figure 18. Uric Acid-lowering Drugs Sales Share by Manufacturers in 2025
Figure 19. Global Uric Acid-lowering Drugs Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Uric Acid-lowering Drugs Players: Market Share by Revenue in Uric Acid-lowering Drugs in 2025
Figure 21. Uric Acid-lowering Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Uric Acid-lowering Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Uric Acid-lowering Drugs Sales Market Share by Country (2021–2032)
Figure 24. North America Uric Acid-lowering Drugs Revenue Market Share by Country (2021–2032)
Figure 25. United States Uric Acid-lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Uric Acid-lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Uric Acid-lowering Drugs Sales Market Share by Country (2021–2032)
Figure 28. Europe Uric Acid-lowering Drugs Revenue Market Share by Country (2021–2032)
Figure 29. Germany Uric Acid-lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Uric Acid-lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Uric Acid-lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Uric Acid-lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Uric Acid-lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Uric Acid-lowering Drugs Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Uric Acid-lowering Drugs Revenue Market Share by Region (2021–2032)
Figure 36. China Uric Acid-lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Uric Acid-lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Uric Acid-lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Uric Acid-lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Uric Acid-lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Uric Acid-lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Uric Acid-lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Uric Acid-lowering Drugs Sales Market Share by Country (2021–2032)
Figure 44. Latin America Uric Acid-lowering Drugs Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Uric Acid-lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Uric Acid-lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Uric Acid-lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Uric Acid-lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Uric Acid-lowering Drugs Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Uric Acid-lowering Drugs Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Uric Acid-lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Uric Acid-lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Uric Acid-lowering Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Uric Acid-lowering Drugs by Type (2021–2032)
Figure 55. Global Revenue Market Share of Uric Acid-lowering Drugs by Type (2021–2032)
Figure 56. Global Uric Acid-lowering Drugs Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Uric Acid-lowering Drugs by Application (2021–2032)
Figure 58. Global Revenue Market Share of Uric Acid-lowering Drugs by Application (2021–2032)
Figure 59. Global Uric Acid-lowering Drugs Price (US$/Unit) by Application (2021–2032)
Figure 60. Uric Acid-lowering Drugs Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
